dr. Komang Ayu Witarini, Sp.A(K)
Education
• Medical doctor: Faculty of Medicine, Udayana University, 2001
• Spesialist: Department of Child Health, Airlangga University, 2009
• Fellowship Allergy-Immunology: Department of Child Health, VuMC-AMC, Netherland, 2013
• Consultant: Department of Child Health, Indonesia University, 2017
Position
Staff of Allergy-Immunology Division, Department of Child Health Faculty of Medicine Udayana University/Udayana University Hospital
Organization
• Member, Indonesian Medical Association
• Member, Indonesian Pediatric Society
• Member, Allergy-Immunology Working Group Indonesian Pediatric Society
• Member, Indonesian Society of Allergy and Immunology
B-Cell Symposium, August 10, 2019
Komang Ayu Witarini
Division of Alergy-Immunology, Child Health Department, Faculty of medicine Udayana University/Udayana University Hospital
THE NEW INSIGHT IN
MANAGEMENT OF COW ’ S MILK PROTEIN ALLERGY
B-Cell Symposium, August 10, 2019
3
OUTLINE
B-Cell Symposium, August 10, 2019
• Introduction
• Approach to cow’s milk protein allergy
• Cow’s milk protein allergy Guideline
• Feeding option in cow’s milk protein allergy
• Cow ’ s milk products
• Evaluation
• Prevention
• Conclusions
4
• Cow’s milk and egg are the most common food allergen in infant and young Asia children1
• Sensitization on atopic dermatitis patients in Pediatric Allergy Clinic RSCM Hospital2 and Sanglah Hospital3
1. Lee AJ, Thalayasingam M, Lee BW, Asia Pac Allergy 2013;3(1):3-14 2. Munasir ZM, Muktiarti D. Asia Pac Allergy. 2013; 3(1): 23–8
3. Witarini KA [Tesis]. Jakarta:FKUI, 2017
White egg (31%) Cow’s milk (23,8%) Chicken (23,8%) Yolk egg (21%) Nuts (21%)
RSCM Pediatric Allergy Clinic (2013)
Egg (36,4%)
Cow’s milk (36,4%) Soy (36,4%)
Shrimp (27,3%) Oyster (27,3%)
Sanglah Pediatric Allergy Clinic (2017)
B-Cell Symposium, August 10, 2019
INTRODUCTION
B-Cell Symposium, August 10, 2019 5
• Cow’s milk protein allergy (CMPA) is defined as an immune-mediated adverse reaction to cow’s milk protein
- Must be distinguished from a variety of adverse reactions to CMP that do not have an immune basis but may resemble it in clinical
manifestations
• Most of them diagnosed before 1 year of age
• CMPA had great impact on the patient if mistreated
Introduction…
B-Cell Symposium, August 10, 2019 6
History Clinical
manifestations
Allergy test
- Confirmed allergy with an allergen(s)
specific avoidance/
immunotherapy - Prevent unnecessary
avoidance
Elimination Provocation and
Test
APPROACH TO CMPA
B-Cell Symposium, August 10, 2019 7
Skin
Atopic dermatitis, urticaria, angioedema
Respiratory tract Rhinitis, asthma
Gastrointestinal
Nausea, vomit, diarrhea, Rectal bleeding
Systemic Anaphylactic Sign and
symptoms…
Host A,.Ann Allergy Asthma Immunol .2002;89:33–7 DRACMA, WAO, 2010
Clinical Manifestation
8
Prevalece of allergic symptoms
Atopic dermatitis
Asthma
0 1 3 7 15 year
Adapted from holgate S,Church MK. eds. Allergy, London: Gower Medical Publishing, 1993
Allergic rhinitis
Food allergy
• Typical sequence of allergic symptoms
• Appearing during early childhood, persist over years or decades
• Often remit
spontaneously with age
B-Cell Symposium, August 10, 2019
Atopic March
9
COW’S MILK PROTEIN ALLERGY GUIDELINE
B-Cell Symposium, August 10, 2019
Algorithm for the diagnosis CMPA
in exclusively breast-fed infants Suspicion of CMPA
History, clinical examination, risk factors
Mild/moderate CMPA
Continue breastfeeding, avoid cow’s milk and its products in mother’s diet (2-4 weeks)
Improvement (+)
Reintroduce cow’s milk in mother’s diet Symptoms (+)
CMPA
Symptoms (-)
Consider other etiology
Improvement (-)
Severe CMPA
Refer IgE Specific/SPT of CMP
Allergy Immunology Working Group, Indonesian Pediatric Society, 2010 10
Algorithm for the diagnosis CMPA in formula fed infants
Suspicion of CMPA
History, clinical examination, risk factors
Mild/moderate CMPA
Extensively hydrolyzed formula (2-4 weeks)*
Improvement (+) Open challenge Symptoms (+)
CMPA
Symptoms (-) Consider other
etiology
Improvement (-) Amino acid formula
Or consider other etiology
Severe CMPA Refer Amino acid
formula IgE Specific/SPT of CMP
* Soy based formula can be used in infants 0-12 months of age if there is tolerability/cost/
availability issue
Allergy Immunology Working Group, Indonesian Pediatric Society, 2010 11
MILD/MODERATE CMPA
One/more following symptoms:
- GI tract: frequent
regurgitation, vomiting, diarrhoea, constipation
(with/without perianal rash), blood in stool
- Iron deficiency anemia - Skin: dermatitis atopic,
urtikaria, angioedema - Rhinitis, asthma
- Persistent colic (> 3 hours daily, at least 3 days/week, over a period of 3 weeks)
SEVERE CMPA
One/more following symptoms:
- Failure to thrive because of diarrhoea/regurgitation/vomit ing/refusal to feed
- Moderate/large amount of blood in the stool with
decreased haemoglobin
- Protein-lossing enteropathy - Severe DA with
anemia/hypoalbuminemia/fail ure to thrive
- Laringoedema or bronchus obstruction
- Anaphylactic shock
Allergy Immunology Working Group, Indonesian Pediatric Society, 2010 12
13
FEEDING OPTION IN COW’S MILK PROTEIN ALLERGY
B-Cell Symposium, August 10, 2019
14
Protein In Cow’s Milk
B-Cell Symposium, August 10, 2019
Fraction/protein Allergen
[1] g/l ~30 % Total
protein 80 MW
(kDa) AA PI
Caseins
Alphas1-casein 12-15 29 23.6 199 4.9-5.0
Alphas2-casein 3-4 8 25.2 207 5.2-5.4
Beta-casein 9-11 27 24.0 209 5.1-5.4
Gamma1-casein Bos d 8 20.6 180 5.5
Gamma2-casein 1-2 6 11.8 104 6.4
Gamma3-casein 11.6 102 5.8
Kappa-casein 3-4 10 19.0 169 5.4-5.6
~5.0 20 Whey proteins
Alpha-lactalbumin Bos d 4 1-1.5 5 14.2 123 4.8
Beta-lactoglobulin Bos d 5 3-4 10 18.3 162 5.3
Immunoglobulin Bos d 7 0.6-1.0 3 160.0 - -
BSA Bos d 6 0.1-0.4 1 67.0 583 4.9-5.1
Lactoferrin - 0.09 traces 800.0 703 8.7
AA = Amino acids; BSA = bovine serum albumin.
Protein Hydrolysates: Different Types
Allergenicity
intact protein pHF eHF Amino acids
Prevention
Treatment
15
16
Extensively Hydrolyzed Formula
B-Cell Symposium, August 10, 2019
• Contains only peptides that have a MW <3,000 d
• >90% tolerance in IgE-CMPA
• First choice for cows milk substitution, especially in infants under 6 months old
• Bitter, expensive
Greer FR, et al. Pediatrics 2008;121:183-91
17
Growth in children with eHF
No long-term consequences of different formulas on BMI
were observed
Note:
• Solid blue line, pHF-W (partially hydrolyzed whey
• Solid green line: eHF-W (extensively hydrolyzed whey
• Solid red line: eHF-C (extensively hydrolyzed casein
• Solid yellow line: CMF (cow-milk formula)
• Gray line:BF (exclusively breastfed for 16 wk
• Dashed red line: 95% prediction band around the trajectory of the eHF-C study group
Am J Clin Nutr. 2009;89:1846–56.
B-Cell Symposium, August 10, 2019
18
Amino Acid Formula
B-Cell Symposium, August 10, 2019
Greer FR, et al. Pediatrics 2008;121:183-91
• Peptide-free formulas that contain mixtures of essential and nonessential amino acids
• Lack allergenicity
• First choice for CMPA patients with severe allergic reaction
• Expensive
19
Soy Formula
B-Cell Symposium, August 10, 2019
• <10% soy allergy among IgE-CMPA
• Soy formula can be use as cow’s milk substitution in patients with IgE-mediated CMPA, age 0-12 months (Indonesian guideline)
• In Australian guidelines:
• Soy formula is recommended as first choice for infants with immediate food reactions, and for those with
gastrointestinal symptoms or atopic dermatitis in the absence of failure to thrive
DRACMA, WAO, 2010 MJA 2008; 188: 109–112
20
Growth in Children with Soy Formula
B-Cell Symposium, August 10, 2019
J Nutr 2004;134:1220S-24S
21
Commercial Foods that Frequently Contain Unexpected Allergens
B-Cell Symposium, August 10, 2019
Foods Containing Milk Protein Breads and bread crumbs
English muffin Flavored crackers Nondairy creamer Instant noodle cups Sorbets
Soy cheese Waffles
Canned fish
Baby foods with mixed ingredients
Most mammalian milks cross-react with cow's milk (e.g. sheep, goat)
Pediatric allergy: principles and practice. 2ndedition
22
Label Reading
B-Cell Symposium, August 10, 2019
Pediatric allergy: principles and practice. 2ndedition
Milk Milk
Artificial butter flavor, butter, buttermilk
Casein (rennet), caseinates (calcium, magnesium, potassium, and sodium) Ghee
Hydrolysates (casein, milk, protein, and whey)
Lactalbumin, lactoglobulin, lactose (maycontain), lactulose Milk solids, milk powder, nonfat dry milk powder
Whey
Label ingredients that may indicate the presence of milk protein Chocolate
Flavorings (artificial, caramel, and natural) High-protein flour
Luncheon meats Margarine
Takaran Saji : 1 Bungkus (30g) Jumlah Sajian peKemasan : 0,5 JUMLAH PERSAJIAN
Energi Total 160 kkal Energi dari Lemak 50 Kkal
%AKG
Lemak Total 5 g 8 %
Lemak jenuh 2 g 10 %
Kolesterol 0 mg 0 %
Protein 3 g 6 %
karbohidrtat Total 20 g 7 % Serat Pangan
Gula Natrium
2 g 1 g 216 mg
8 % 13
%
Kalium 51 mg 1 %
Vitamin A 0 %
Vitamin C 0 %
Kalsium 0 %
Zat Besi 0 %
Informasi Nilai Gizi
KOMPOSISI: Tepung Terigu, Lemak Nabati, Gula, Garam, Perisa Daging Asap, Keju Bubuk, Whey Bubuk, Ragi,
Penguat Rasa Monosodium Glutamat, Daun Bawang Kering, Penguat Rasa Hidrolisat Protein Sayuran, Pewarna
Makanan, Tartrazin Cl 19140.
ContohProduk
23
ContohProduk
KOMPOSISI: Beras, Jagung, Dektrosa, Minyak Nabati, Gula, Bubuk Kedelai, Bubuk Whey, Telur Bubuk, Penguat Rasa (MSG), Garam.
Takaran Saji :
Jumlah Sajian per Kemasan :
25 g 2
JUMLAH PERSAJIAN Energi Total
Energi dari Lemak
160kkal 50Kkal
Lemak Total Protein Karbohidrtat Total Natrium
3g 2g 20g 70mg
%AKG 5%
4%
6%
3%
Informasi NilaiGizi
24
ContohProduk
KOMPOSISI: Beras, Protein Soya, Susu Full Cream, Susu Skim, Minyak Soya, Minyak Bawang, Lesitin Soya, Daging Ayam, Jagung Manis, Bumbu, Premix
Vitamin dan Premix Mineral.
Takaran Saji
Jumlah Sajian per Kemasan
1 sachet (25g)
4 JUMLAHPERSAJIAN
Energi total 100 kkal Lemak Total Omega 3 Omega 6 Lestin Karbohidrat total Serat Makanan PrebiotikFOS Gula Protein
1.5 g 0.07 5 g
0.25 g A0.1
0 g 19 g 1 g 0.5 g 1 g 3g
Informasi Nilai Gizi
10% Asam folat 4 % 25% Asam Pantotenat 40 %
%AKG Protein Vitamin A Vitamin D Vitamin E Vitamin K Vitamin C Vitamin B1 Vitamin B2 Vitamin B6
50% Biotin 15% Kolin 40% Inositol 30% Natrium 15% Kalsium 20% Zat Besi 15% Kalium Vitamin B12 60% Yodium
3.75 Mcg 12.5 mg 5 mg 20 % 15 % 30 % 8 % 15 %
25
ContohProduk
KOMPOSISI: Beras Merah, Kedelai, Gula, Minya Kelapa Sawit, Mineral, Premiks Vitamin, Pengemulsi Lesitin
Kedelai, dan Vanila. Dapat
Mengandung sekelumit protein susu dan/atau gluten.
Takaran saji 3 sendokmakan(30 g) Jumlah Sajianperkemasan:sekitar2 JUMLAHPERSAJIAN
Energi Total 230kkal
4.5g 1.5g 8g 14 g Lemak
Asam Linoleut Protein Karbohidrat 34 g Serat Pangan 2 g Gula Natrium 6.5 mg Protein Vitamin A Vitamin D Vitamin E Vitamin B1 (Tomin) Vitamin B2 Vitamin B3 Vitamin B5 Vitamin B6 Vitamin B9 Vitamin B12 Vitamin C Kalsium Fosfor Zat Besi Yodium Zink
%AKG 34%
40%
50%
30%
40%
40%
40%
40%
100%
15%
50%
65%
45%
55%
50%
25%
25%
Persajianmengandung:
Kalsium/Fosfor 1.2
26
27
EVALUATION
B-Cell Symposium, August 10, 2019
Natural course of CMPA
First Year Second Year Third Year
45-55% 60-75%
90%
90%
Outgrown
Arch Dis Child. 2007;92;902-8 Med Clin N Am 2006;90:97-127
28
Evaluation…
B-Cell Symposium, August 10, 2019
Periodic Review
• Periodic review every 6 months
• Open challenge – Symptoms (+):
• Still allergy avoidance
• Review another 6 months – Symptoms (-)
• Tolerance reintroduce cow’s milk
29
PREVENTION
B-Cell Symposium, August 10, 2019
As management should involve prevention:
Identification those with allergic risk
EXCLUSIVE BREAST FEEDING Partial Hidrolisat Formula
5-15%
jika orangtua tidak memiliki
riwayat alergi
25%-30%
jika saudara memiliki riwayat alergi
20%-30%
jika salah satu orangtua memiliki
riwayat alergi
40%-60%
jika kedua orangtua memiliki
riwayat alergi
60%-80%
Jika kedua orang tua memiliki manifestasi
sama
Risiko Alergi
Riwayat Keluarga AlergiPositif
30
31
Efficacy of Prevention
B-Cell Symposium, August 10, 2019
10pHF versus cow's milk formula in high risk infants.
significant reduction in infant allergy (7 studies, 2514 infants; typical RR 0.79, 95% CI 0.66, 0.94), but not in the incidence of childhood allergy (2 studies, 950 infants; typical RR 0.85, 95% CI 0.69, 1.05).
Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003664
Meta-analysis: on partially hydrolyzed formula
32
Efficacy of Prevention
B-Cell Symposium, August 10, 2019
Efficacy of Breast Feeding
33
CONCLUSIONS
B-Cell Symposium, August 10, 2019
• Management of CMPA is strict avoidance of cow’s milk protein and its products.
• Feeding options:
– Extensive hydrolyzed formula – Amino acid formula
– Soy formula
• Periodic review is needed to prevent unnecessarily prolonged elimination diets
• Prevention on infant with allergic risk reduced prevalence of CMPA
34
THANK YOU
B-Cell Symposium, August 10, 2019